Below are the most recent publications written about "Antifungal Agents" by people in Profiles.
-
Fallah S, Duncan D, Reichl KD, Smith MJ, Wang W, Porco JA, Brown LE, Whitesell L, Robbins N, Cowen LE. A chemical screen identifies structurally diverse metal chelators with activity against the fungal pathogen Candida albicans. Microbiol Spectr. 2024 Apr 02; 12(4):e0409523. PMID: 38376363.
-
Papadopoulos EA, Howley MM, Fisher SC, Van Zutphen AR, Werler MM, Romitti PA, Browne ML. Antifungal medication use during early pregnancy and the risk of congenital heart defects in the National Birth Defects Prevention Study, 1997-2011. Birth Defects Res. 2024 Feb; 116(2):e2308. PMID: 38343154.
-
Papadopoulos EA, Howley MM, Fisher SC, Van Zutphen AR, Werler MM, Romitti PA, Browne ML. Antifungal medication use during pregnancy and the risk of selected major birth defects in the National Birth Defects Prevention Study, 1997-2011. Pharmacoepidemiol Drug Saf. 2024 Jan; 33(1):e5741. PMID: 38112229.
-
Person AK, Crabtree-Ramirez B, Kim A, Veloso V, Maruri F, Wandeler G, Fox M, Moore R, John Gill M, Imran D, Van Nguyen K, Nalitya E, Muyindike W, Shepherd BE, McGowan CC. Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View. Clin Infect Dis. 2023 Jun 16; 76(12):2116-2125. PMID: 36821489.
-
Dallalzadeh LO, Ediriwickrema LS, Fung SE, Men CJ, Kossler AL, Kupcha AC, Mawn LA, Burkat CN, van Landingham SW, Conger JR, Simmons B, Pham C, Akella SS, Setabutr P, Ho T, Couch SM, Kim JS, Demirci H, Korn BS, Kikkawa DO, Liu CY. Transcutaneous retrobulbar amphotericin B for rhino-orbital-cerebral mucormycosis: a multi-center retrospective comparative study. Orbit. 2024 Feb; 43(1):41-48. PMID: 36880205.
-
Veringa A, Brüggemann RJ, Span LFR, Biemond BJ, de Boer MGJ, van den Heuvel ER, Klein SK, Kraemer D, Minnema MC, Prakken NHJ, Rijnders BJA, Swen JJ, Verweij PE, Wondergem MJ, Ypma PF, Blijlevens N, Kosterink JGW, van der Werf TS, Alffenaar JC. Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial. Int J Antimicrob Agents. 2023 Feb; 61(2):106711. PMID: 36642232.
-
Haedenkamp TM, Leitzmann MF, Linker RA, Meier C, Becker C, Jick S, Hau P, Seliger C. Antimicrobial drug use and the risk of glioma: A case-control study. Cancer Med. 2023 Feb; 12(3):3684-3695. PMID: 36066038.
-
Rajasingham R, Nalintya E, Israelski DM, Meya DB, Larson BA, Boulware DR. Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries. Med Mycol. 2022 Feb 01; 60(2). PMID: 35026017.
-
Elhamamsy S, Bayer T, Al-Kaffas M, Hatahet S, Grover M, Samdhani S, Nanda A, Gravenstein S. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19. R I Med J (2013). 2021 Oct 01; 104(8):19-21. PMID: 34582509.
-
Marcyk PT, LeBlanc EV, Kuntz DA, Xue A, Ortiz F, Trilles R, Bengtson S, Kenney TMG, Huang DS, Robbins N, Williams NS, Krysan DJ, Privé GG, Whitesell L, Cowen LE, Brown LE. Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors: Optimization of Whole-Cell Anticryptococcal Activity and Insights into the Structural Origins of Cryptococcal Selectivity. J Med Chem. 2021 01 28; 64(2):1139-1169. PMID: 33444025.